Breakthrough in the fight against pancreatic cancer: Kiel research team gives hope

Breakthrough in the fight against pancreatic cancer: Kiel research team gives hope

an innovative breakthrough in cancer research

pancreatic cancer is one of the most aggressive types of cancer, which was previously considered incurable and meant a bad prognosis for patients. But thanks to the groundbreaking research of the team around Dr. Markus Vogt at the Biochemical Institute of the Christian Albrechts University in Kiel is a promising future.

The search for new therapy options

The Kiel research team focused on the driver gene Myc, which promotes the growth of pancreatic tumors. By inhibiting the RUVBL1 protein, which is closely connected to MyC, the researchers hope to stop the actual trigger for cancer development. This innovative approach could open the door to new therapies against pancreatic cancer.

exceeded expectations and future prospects

The previous results of research have exceeded the expectations of the scientists. Not only do the tumor cells shrink when inhibiting RUVBL1, but also an increased immigration of the body's immune cells into the tumor. These promising developments could pave the way for effective cancer therapies and significantly improve the forecast for patients with pancreatic cancer.

outlook on a promising future

The researchers Dr. Markus Vogt and Prof. Dr. Elmar Wolf are confident that her work paves the way for new treatment options for pancreatic cancer. Nevertheless, it will still take a few years for appropriate medication to be available on the market. However, progress in cancer research gives hope for patients and shows that research is breaking new ways to combat cancer.